These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9063009)

  • 41. [Vulvar melanosis and vitiligo].
    Haraszti G; Kemény L; Bónis B; Dobozi A
    Orv Hetil; 1998 Apr; 139(14):825-8. PubMed ID: 9569730
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vivo evaluation of piperine and synthetic analogues as potential treatments for vitiligo using a sparsely pigmented mouse model.
    Faas L; Venkatasamy R; Hider RC; Young AR; Soumyanath A
    Br J Dermatol; 2008 May; 158(5):941-50. PubMed ID: 18284389
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Repigmentation in vitiligo universalis: role of melanocyte density, disease duration, and melanocytic reservoir.
    Dogra S; Kumar B
    Dermatol Online J; 2005 Dec; 11(3):30. PubMed ID: 16409926
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Melanocytes: the new Black.
    Goding CR
    Int J Biochem Cell Biol; 2007; 39(2):275-9. PubMed ID: 17095283
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Vitiligo].
    Prigent F
    Arch Pediatr; 2007 Feb; 14(2):219-20. PubMed ID: 17223326
    [No Abstract]   [Full Text] [Related]  

  • 46. Lentigines within nevus depigmentosus: a rare collateral effect of UVB therapy?
    Bardazzi F; Balestri R; Antonucci A; Spadola G
    Pediatr Dermatol; 2008; 25(2):272-4. PubMed ID: 18429802
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Camouflaging vitiligo of the fingers.
    Tanioka M; Miyachi Y
    Arch Dermatol; 2008 Jun; 144(6):809-10. PubMed ID: 18559781
    [No Abstract]   [Full Text] [Related]  

  • 48. The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial.
    Esfandiarpour I; Ekhlasi A; Farajzadeh S; Shamsadini S
    J Dermatolog Treat; 2009; 20(1):14-8. PubMed ID: 18608735
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of autologous transplantation of noncultured epidermal suspension in two different dilutions in the treatment of vitiligo.
    Tegta GR; Parsad D; Majumdar S; Kumar B
    Int J Dermatol; 2006 Feb; 45(2):106-10. PubMed ID: 16445497
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Little white spots: an approach to hypopigmented macules.
    Lio PA
    Arch Dis Child Educ Pract Ed; 2008 Jun; 93(3):98-102. PubMed ID: 18495902
    [No Abstract]   [Full Text] [Related]  

  • 51. A rare repigmentation pattern in a vitiligo patient: a clue to an epidermal stem-cell reservoir of melanocytes?
    Davids LM; du Toit E; Kidson SH; Todd G
    Clin Exp Dermatol; 2009 Mar; 34(2):246-8. PubMed ID: 18828846
    [No Abstract]   [Full Text] [Related]  

  • 52. Randomized, double-blind clinical trial to evaluate the efficacy of topical tacalcitol and sunlight exposure in the treatment of adult nonsegmental vitiligo.
    Rodríguez-Martín M; García Bustínduy M; Sáez Rodríguez M; Noda Cabrera A
    Br J Dermatol; 2009 Feb; 160(2):409-14. PubMed ID: 19016706
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Endothelin-1 is significantly elevated in plasma of patients with vitiligo treated with psoralen plus ultraviolet A.
    Abdel-Naser MB; El-Khateeb EA; Sallam TH; Habib MA
    Clin Exp Dermatol; 2006 Jul; 31(4):571-5. PubMed ID: 16716165
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Spontaneous repigmentation in vitiligo: why it is important.
    Malakar S; Lahiri K
    Int J Dermatol; 2006 Apr; 45(4):478-9. PubMed ID: 16650185
    [No Abstract]   [Full Text] [Related]  

  • 55. What you need to know about .... vitiligo.
    Nurs Times; 2003 Dec 9-15; 99(49):27. PubMed ID: 14705342
    [No Abstract]   [Full Text] [Related]  

  • 56. A case study to evaluate the treatment of vitiligo with khellin encapsulated in L-phenylalanin stabilized phosphatidylcholine liposomes in combination with ultraviolet light therapy.
    de Leeuw J; van der Beek N; Maierhofer G; Neugebauer WD
    Eur J Dermatol; 2003; 13(5):474-7. PubMed ID: 14693493
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [New treatments for vitiligo?].
    Herbst RA
    Med Monatsschr Pharm; 2007 Oct; 30(10):379-80. PubMed ID: 17966288
    [No Abstract]   [Full Text] [Related]  

  • 58. Koebnerization of donor site in unilateral vitiligo patients, treated successfully by autologous, noncultured melanocyte-keratinocyte (MK) cell transplantation.
    Mulekar SV; Al Eissa A; Asaad M
    Clin Exp Dermatol; 2005 Jul; 30(4):445-6. PubMed ID: 15953098
    [No Abstract]   [Full Text] [Related]  

  • 59. Basic research confirms coexistence of acquired Blaschkolinear Vitiligo and acrofacial Vitiligo.
    Schallreuter KU; Krüger C; Rokos H; Hasse S; Zothner C; Panske A
    Arch Dermatol Res; 2007 Aug; 299(5-6):225-30. PubMed ID: 17404749
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Repigmentation of skin and hairs in stable vitiligo by transplantation of autologous melanocytes in fibrin suspension.
    Hartmann A; Broecker EB; Hamm H
    J Eur Acad Dermatol Venereol; 2008 May; 22(5):624-6. PubMed ID: 18410624
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.